|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
|
|---|---|---|---|---|---|
| Net income | |||||
| Cash Flows from Operating Activities: | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Deferred income tax | |||||
| Impairments of property, plant and equipment and goodwill | |||||
| Net loss on sale/retirement of assets | |||||
| Gain on extinguishment of debt | |||||
| Equity in (earnings) losses of equity method affiliate, net | |||||
| Return on investment in equity method affiliate | |||||
| Equity-based compensation | |||||
| Amortization of debt costs and discount (premium) | |||||
| Changes in other assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Accounts receivable—affiliated companies | |||||
| Inventory | |||||
| Gas imbalance assets | |||||
| Other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accounts payable—affiliated companies | |||||
| Gas imbalance liabilities | |||||
| Other current liabilities | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Capital expenditures | |||||
| Acquisitions, net of cash acquired | |||||
| Proceeds from sale of assets | |||||
| Proceeds from insurance | |||||
| Return of investment in equity method affiliate | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Increase (decrease) increase in short-term debt | |||||
| Proceeds from long-term debt, net of issuance costs | |||||
| Repayment of long-term debt | |||||
| Proceeds from Revolving Credit Facility | |||||
| Repayment of Revolving Credit Facility | |||||
| Repayment of notes payable—affiliated companies | |||||
| Proceeds from issuance of common units, net of issuance costs | |||||
| Proceeds from issuance of Series A Preferred Units, net of issuance costs | |||||
| Distributions to common unitholders | |||||
| Distributions to subordinated unitholders | |||||
| Distributions to preferred unitholders | |||||
| Distributions to non-controlling interests | |||||
| Cash paid for employee equity-based compensation | |||||
| Net cash (used in) provided by financing activities | |||||
| Net (Decrease) Increase in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents at Beginning of Period | |||||
| Cash and Cash Equivalents at End of Period | |||||
Loading...